|
|
|
|
LEADER |
01965nam a22003375i 4500 |
001 |
000282828 |
005 |
20211101114352.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781603270489
|
024 |
7 |
|
|a 10.1007/978-1-60327-048-9
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Essential Concepts in Toxicogenomics /
|c edited by Donna L. Mendrick, William B. Mattes.
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2008.
|
300 |
|
|
|a XI, 277 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in Molecular Biology,
|v 460
|
505 |
0 |
|
|a Toxicogenomics and Classic Toxicology: How to Improve Prediction and Mechanistic Understanding of Human Toxicity -- Use of Traditional End Points and Gene Dysregulation to Understand Mechanisms of Toxicity: Toxicogenomics in Mechanistic Toxicology -- Quality Control of Microarray Assays for Toxicogenomic and In Vitro Diagnostic Applications -- Role of Statistics in Toxicogenomics -- Predictive Toxicogenomics in Preclinical Discovery -- In Vivo Predictive Toxicogenomics -- Bioinformatics: Databasing and Gene Annotation -- Microarray Probe Mapping and Annotation in Cross-Species Comparative Toxicogenomics -- Toxicogenomics in Biomarker Discovery -- From Pharmacogenomics to Translational Biomarkers -- Public Consortium Efforts in Toxicogenomics -- Applications of Toxicogenomics to Nonclinical Drug Development: Regulatory Science Considerations.
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Bioinformatics.
|
650 |
1 |
4 |
|a Human Genetics.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Bioinformatics.
|
700 |
1 |
|
|a Mendrick, Donna L.
|e editor.
|
700 |
1 |
|
|a Mattes, William B.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|